Private Equity
Acorn Bioventures has set out to raise a venture-capital fund, according to a filing with the SEC.
1 min read · 06 March 2019
Pacira Pharmaceuticals Inc has agreed to acquire MyoScience, a medical tech company. Pacira will make an initial payment of $120 million with an additional $100 million contingent upon the fulfillment of certain milestones. MyoScience's backers include Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Nexus Medical Partners, Valiance and Sobera Capital.
6 min read · 06 March 2019
Seattle-based Tasso Inc, a blood collection startup, has raised $6.1 million in financing. Vertical Venture Partners led the round with participation from Techstars and Cedars-Sinai.
1 min read · 06 March 2019
3 min read · 06 March 2019
Arthur Ventures has raised almost $7 million for its 2017 opportunity fund, according to an SEC filing. The target is $20 million. Arthur Ventures invests in early-stage B2B software companies located outside Silicon Valley.
1 min read · 06 March 2019
South Summit and Red Capital Partners have launched a venture fund. The South Summit Fund will invest 6 million euros per year among the finalist startups in South Summit's startup competition.
4 min read · 06 March 2019
Disruption Ventures has secured an undisclosed investment for its inaugural fund from Scotiabank, a Canadian banking institution. Scotiabank led commitments of $13 million for the $30 million Disruption Ventures I LP, according to the Globe and Mail. In a separate statement, Canadian wealth manager CI Financial Corp said it committed $2 million. Founded last year by Managing Partner Elaine Kunda, a Canadian digital and e-commerce entrepreneur, Toronto-based Disruption invests in early-stage companies founded or managed by women. It expects to close Fund I and make initial investments this year.
3 min read · 06 March 2019
1 min read · 06 March 2019
1 min read · 06 March 2019
3 min read · 05 March 2019
